September 23, 2016 — IBA unveiled its new platform, 'Leading the PATh', which gathers the leading experts in the field of proton therapy all in one place. It is anticipated that 'Leading the PATh' will enable the worldwide medical community to shape the most efficient proton adaptive therapy (PATh), a proton therapy process which improves the accuracy of what is considered to be the most precise cancer treatment available today.
The platform www.leadingthepath.org will enable physicians, physicists, academics, researchers, industry experts, patient association advocates and policymakers from all over the world to exchange experiences, discuss best practices and enhance knowledge, to improve the next generation of proton therapy treatment.
This platform also includes access to a research software platform. This software will be distributed under an open-source license to foster creativity and innovation within the proton therapy community. In addition, users will be invited to access and test a software application that proposes a new example of proton adaptive workflow.
For more information: www.iba-worldwide.com
September 28, 2023 
